RespireRx Pharmaceuticals Market Cap

RespireRx Pharmaceuticals has a market cap or net worth of $569.68 thousand as of June 27, 2025. Its market cap has decreased by -39.78% in one year.

Market Cap

569.68K

Enterprise Value

n/a

Revenue

n/a

Ranking

n/a

PE Ratio

n/a

Stock Price

$0.00

Market Cap Chart

Since May 1, 1992, RespireRx Pharmaceuticals's market cap has decreased from 26.39M to 569.68K, a decrease of -97.84%. That is a compound annual growth rate of -10.92%.

Market Cap History

Date	Market Cap	% Change
Jun 26, 2025	569.68K	-25.00%
Dec 31, 2024	759.57K	65.58%
Dec 29, 2023	458.74K	58.87%
Dec 30, 2022	288.75K	-74.38%
Dec 31, 2021	1.13M	-45.46%
Dec 31, 2020	2.07M	411.01%
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Endo, Inc.	1.59B
Elite Pharmaceuticals	827.70M
Veradigm	764.23M
Nika Pharmaceuticals	708.22M
Tian'an Technology Group	628.15M
American Oncology Network	420.90M
CytoDyn	404.64M
Glass House Brands	389.15M

Market Cap Rankings